ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
JonesingPanda
|
27 |
5.8K |
15 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
27
|
5.8K
|
15
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Compelling 85% Success Rate Remplir Study now published
|
|
JonesingPanda
|
13 |
4.0K |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
13
|
4.0K
|
12
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024
|
|
JonesingPanda
|
24 |
7.9K |
16 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
7.9K
|
16
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
JonesingPanda
|
1.3K |
341K |
5 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.3K
|
341K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
JonesingPanda
|
37 |
9.0K |
35 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.0K
|
35
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
31 |
8.4K |
19 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
31
|
8.4K
|
19
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
JonesingPanda
|
91 |
26K |
6 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
91
|
26K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Strategic Placement to Raise $3.5 million
|
|
JonesingPanda
|
91 |
26K |
6 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
91
|
26K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
JonesingPanda
|
41 |
12K |
7 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
41
|
12K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
JonesingPanda
|
41 |
12K |
14 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
41
|
12K
|
14
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Maiden Purchase Order Secured From Global Denim Manufacturer
|
|
JonesingPanda
|
24 |
6.3K |
3 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
24
|
6.3K
|
3
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Maiden Purchase Order Secured From Global Denim Manufacturer
|
|
JonesingPanda
|
24 |
6.3K |
5 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
24
|
6.3K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
26 |
8.1K |
12 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
26
|
8.1K
|
12
|
|
ASX - By Stock
|
PAB |
Re:
Ann: Appendix 4C - Quarterly - 31 December 2023
|
|
JonesingPanda
|
10 |
4.2K |
14 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
10
|
4.2K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
JonesingPanda
|
1.6K |
475K |
11 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
1.6K
|
475K
|
11
|
|
ASX - By Stock
|
PAB |
Re:
Ann: GMP Production of PAT-DX1 Next Quarter
|
|
JonesingPanda
|
62 |
14K |
5 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
62
|
14K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
JonesingPanda
|
1.6K |
475K |
11 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
1.6K
|
475K
|
11
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Investor Presentation Imbio acquisition and capital raise
|
|
JonesingPanda
|
91 |
32K |
10 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
91
|
32K
|
10
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
JonesingPanda
|
120 |
45K |
17 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
45K
|
17
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
JonesingPanda
|
120 |
45K |
14 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
120
|
45K
|
14
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2023 Annual General Meeting Presentation
|
|
JonesingPanda
|
12 |
5.5K |
0 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
12
|
5.5K
|
0
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: NC6 Enters MOU to Supply MicroGel to Greenspace
|
|
JonesingPanda
|
16 |
4.5K |
5 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
16
|
4.5K
|
5
|
|
ASX - By Stock
|
TRP |
Re:
Ann: Appendix 4E and Annual Report 30 June 2023
|
|
JonesingPanda
|
21 |
4.6K |
3 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
21
|
4.6K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate re-certified under new European medical device regs
|
|
JonesingPanda
|
17 |
5.4K |
5 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
17
|
5.4K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Striate re-certified under new European medical device regs
|
|
JonesingPanda
|
17 |
5.4K |
5 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
17
|
5.4K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
JonesingPanda
|
518 |
161K |
15 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
518
|
161K
|
15
|
|
ASX - By Stock
|
NC6 |
Re:
People on Linkedin are making fun of Nanollose's latest video
|
|
JonesingPanda
|
16 |
4.7K |
12 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
16
|
4.7K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Presenting on LIVE & FREE webinar tomorrow
|
|
JonesingPanda
|
1 |
606 |
5 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
1
|
606
|
5
|
|
ASX - By Stock
|
4DX |
Re:
Frontiers of Imaging - Tomorrow (Melbourne)
|
|
JonesingPanda
|
52 |
17K |
5 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
52
|
17K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
7 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
72
|
21K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
13 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
72
|
21K
|
13
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
12 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
72
|
21K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
16 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
72
|
21K
|
16
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
14 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
72
|
21K
|
14
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
JonesingPanda
|
518 |
161K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
518
|
161K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
JonesingPanda
|
72 |
21K |
13 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
72
|
21K
|
13
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
JonesingPanda
|
348 |
128K |
3 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
348
|
128K
|
3
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
JonesingPanda
|
348 |
128K |
11 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
348
|
128K
|
11
|
|
ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
JonesingPanda
|
58 |
16K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
58
|
16K
|
5
|
|
ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
JonesingPanda
|
58 |
16K |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
JonesingPanda
|
58 |
16K |
2 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
JonesingPanda
|
58 |
16K |
0 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
NC6 |
Re:
FY 24 - surely some action!
|
|
JonesingPanda
|
58 |
16K |
7 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
58
|
16K
|
7
|
|
ASX - By Stock
|
NC6 |
Re:
Ann: Nanollose Receives $374,063 R&D Tax Rebate
|
|
JonesingPanda
|
7 |
2.7K |
1 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
7
|
2.7K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
JonesingPanda
|
217 |
71K |
6 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
217
|
71K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
JonesingPanda
|
217 |
71K |
15 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
217
|
71K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes oversubscribed $25m SPP
|
|
JonesingPanda
|
13 |
6.2K |
6 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
13
|
6.2K
|
6
|
|
ASX - By Stock
|
PAB |
Re:
Ann: PAT-DX1 GLP toxicology reports received
|
|
JonesingPanda
|
62 |
28K |
19 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
62
|
28K
|
19
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
JonesingPanda
|
1.6K |
475K |
15 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
1.6K
|
475K
|
15
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical Investor Webinar Details
|
|
JonesingPanda
|
28 |
8.6K |
1 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
28
|
8.6K
|
1
|
|